BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29220301)

  • 1. Soft Tissue and Uterine Leiomyosarcoma.
    George S; Serrano C; Hensley ML; Ray-Coquard I
    J Clin Oncol; 2018 Jan; 36(2):144-150. PubMed ID: 29220301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Therapeutics in the Treatment of Uterine Sarcoma.
    Bose S; Schwartz GK; Ingham M
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():900-909. PubMed ID: 35714303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
    Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
    Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
    Tsuyoshi H; Yoshida Y
    Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
    Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology and treatment of leiomyosarcomas.
    Kerrison WGJ; Thway K; Jones RL; Huang PH
    Crit Rev Oncol Hematol; 2023 Apr; 184():103955. PubMed ID: 36893945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
    Krishnan V; Sauthier P; Provencher D; Rahimi K
    Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced uterine sarcoma with adriamycin.
    Hannigan EV; Freedman RS; Elder KW; Rutledge FN
    Gynecol Oncol; 1983 Aug; 16(1):101-4. PubMed ID: 6884822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
    Grignani G; Martín-Broto J; Schuler M; Reichardt P
    Future Oncol; 2015; 11(11 Suppl):15-24. PubMed ID: 26043311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the standard of care in metastatic leiomyosarcoma.
    Noujaim J; van der Graaf WT; Jones RL
    Lancet Oncol; 2015 Apr; 16(4):360-2. PubMed ID: 25795407
    [No Abstract]   [Full Text] [Related]  

  • 12. Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kanai Y; Shiozawa T; Tonegawa S; Konishi I
    Protein Cell; 2010 Aug; 1(8):711-7. PubMed ID: 21203912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
    Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
    Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond.
    Croce S; Chibon F
    Genes Chromosomes Cancer; 2021 Mar; 60(3):129-137. PubMed ID: 33099852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.
    Sagae S; Yamashita K; Ishioka S; Nishioka Y; Terasawa K; Mori M; Yamashiro K; Kanemoto T; Kudo R
    Oncology; 2004; 67(1):33-9. PubMed ID: 15459493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.
    Takano T; Niikura H; Ito K; Nagase S; Utsunomiya H; Otsuki T; Toyoshima M; Tokunaga H; Kaiho-Sakuma M; Shiga N; Nagai T; Tanaka S; Otsuki A; Kurosawa H; Shigeta S; Tsuji K; Yamaguchi T; Yaegashi N
    Int J Clin Oncol; 2014 Oct; 19(5):897-905. PubMed ID: 24149774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy.
    Ray-Coquard I; Rizzo E; Blay JY; Casali P; Judson I; Hansen AK; Lindner LH; Dei Tos AP; Gelderblom H; Marreaud S; Litière S; Rutkowski P; Hohenberger P; Gronchi A; van der Graaf WT
    Gynecol Oncol; 2016 Jul; 142(1):95-101. PubMed ID: 27208537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
    Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
    Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine sarcoma - time is worth its weight in gold.
    Pruski D; Millert-Kalińska S; Mądry R; Kotynia K; Pawełek T; Rusek D; Zmaczyński A; Jach R; Przybylski M
    Pol J Pathol; 2023; 74(1):59-62. PubMed ID: 37306355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
    Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
    Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.